Sun Pharma share price, Sun Pharma stock, Sun Pharma shares, Sun Pharma, Sun Pharma new unit, Sun Pharma to invest 3000 crore in new manufacturing facility, Sun Pharma Madhya Pradesh facility, Sun Pharma 3000 crore investment,
Market
C
CNBC TV1803/12/2025

Sun Pharma unveils ₹3,000 crore expansion in Madhya Pradesh, launches Ilumya in India

  • Sun Pharma to invest ₹3,000 crore in a new facility in Madhya Pradesh.
  • Sun Pharma introduces Ilumya in India for treating plaque psoriasis.
  • Ilumya is endorsed globally as an effective treatment for psoriasis.
  • Sun Pharma's India business continues to grow ahead of the market.
  • Sun Pharma shares have gained 8.2% in the last six months but declined 4.5% this year.

Why it matters: Sun Pharma’s ₹3,000 crore investment may boost healthcare manufacturing and jobs in Madhya Pradesh.

Related Articles

Loading more articles...